Harald Hasselmann
CEO & Chairman of the Executive Board of Medical Segment

Ladies and gentlemen,, this is Harald Hasselmann, CEO of Eckert & Ziegler SE speaking, very much welcome. Good morning and good afternoon. I'm speaking out of Berlin. And together with my colleagues, Karolin Riehle and Julian, whom you all know pretty well, we are going to lead you through the Q1 results, followed by a Q&A session. My presentation, which will last for the first half of today's meeting will be recorded. So for those who cannot participate, you are able to listen to once. Thereafter, whereas the Q&A session is a live session only. So in a nutshell, the Q1 result of 2026 confirms that our strategy is in line and that our numbers are on track. By that, we are also confirming our outlook, which has been published earlier this year. I will lead through the over.

Unknown Analyst

Sorry for interrupting. I only see the title slide. I don't know if the others. That's right.

Harald Hasselmann
CEO & Chairman of the Executive Board of Medical Segment

So I will lead you now through the presentation and just wanted to keep you alerted that the key message of today's Q1 result is everything, as we say here in Germany is on green light. Now let me go through the slides step by step. You know the usual disclaimer, which demonstrates here that everything is based on the legal and overall environment. The Group Executive Committee consists of Gunnar Mann and myself